According to a new study, refining the purification process of therapeutic cells may help in enhancing their use for treating cancer and many other diseases.
Before the cells are transplanted, the cells have to be purified to reduce the inclusion of undesired cell types, with the therapeutic cells that clinicians and researchers want to use.
This process can be unsuitable and limited, where all other cell types are not removed, or can damage the cells needed for a transplant, making them useless.
Hirohide Saito and colleagues are investigating methods that target signatures within cells rather than on the surface.
Their instruments look for specific microRNAs (miRNAs), small molecules that are found in plants and animals, which they believe will prove more selective and damage fewer cells.
miRNAs can switch genes on and off.
The researches have designed a synthetic tool named miRNA switch. The miRNA switch can find these small molecules within the cell.
It has already successfully purified many cell types, so the scientists are able to have samples of solely heart muscle cells, liver cells, cells that line blood vessels or cells that produce insulin.
The percentage of purified cells is far higher than that using standard antibody purification because the markers the tool looks for are more specific than the commonly used antibodies and cell surface receptors.
The cells are also less likely to be damaged compared with antibody-based techniques, because they do not need to be handled as much.
The team hopes to refine the technique so that it is attractive for research and is now working with several groups that are planning for cell based therapies in patients.
The study was published in journal Cell Stem Cell.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
